<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03295812</url>
  </required_header>
  <id_info>
    <org_study_id>004</org_study_id>
    <nct_id>NCT03295812</nct_id>
  </id_info>
  <brief_title>Stratification of Chronic Alcoholic Liver Diseases (SCALE Study)</brief_title>
  <acronym>SCALE</acronym>
  <official_title>Stratification of Chronic Alcoholic Liver Diseases (SCALE Study) Based on Organs Injury: a Multi-center Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanfang Hospital of Southern Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent years, the European Association for the Study of the Liver-chronic liver failure
      (EASL-CLIF) has defined and graded acute-on-chronic liver failure (ACLF) based on CANONIC
      study which enrolled cirrhotic patients with acute decompensation. However, the
      characteristics and definitions of ACLF in non-cirrhotic patients with acute deterioration of
      liver function and organs injury or failure remain to be clear. As for patients who don't
      fulfil ACLF criteria, there might be a subgroup with high risk of progression (&gt;25%) and a
      moderate 4-week mortality rate (&gt;7%), which can be defined as &quot;pre-ACLF&quot;, while the others
      are just chronic liver disease with &quot;mere&quot; liver injury or decompensation. This
      stratification system was primarily verified in a previous retrospective cohort which
      enrolled Hepatitis B patients only. The stratification criteria for chronic alcoholic liver
      disease needs to be further defined in detail. Therefore, investigators plan to prospectively
      recruit 3000 chronic alcoholic hospitalized patients with liver dysfunction from 24
      hepatology departments in China, aiming to propose a stratified diagnostic system for chronic
      alcoholic patients based on organs injury. Meanwhile, risk factors of disease progression and
      short-term mortality will be analyzed, while characteristics and prognosis will be compared
      between patients with and without cirrhosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 16, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>4-week mortality</measure>
    <time_frame>4 weeks</time_frame>
    <description>mortality rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>12-week mortality</measure>
    <time_frame>12 weeks</time_frame>
    <description>mortality rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>4-week progression rate</measure>
    <time_frame>4 weeks</time_frame>
    <description>The proportion of subjects progressed to acute-on-chronic liver failure within 4 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24-week mortality</measure>
    <time_frame>24 weeks</time_frame>
    <description>mortality rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>48-week mortality</measure>
    <time_frame>48 weeks</time_frame>
    <description>mortality rate</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Risk factors for disease progression within 4 weeks</measure>
    <time_frame>4 weeks</time_frame>
    <description>analysis of risk factors for disease progression</description>
  </other_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Alcoholic Liver Disease</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard therapy</intervention_name>
    <description>standard therapy,non-interventional study</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, serum, urine and DNA samples will be reserved
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be selected from all in-patients in 24 hepatology departments
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Long-term alcohol consumption (at least one of the followings):

               1. &gt;40g/d for male and &gt;20g/d for female, at least for 5 years;

               2. &gt;50g/d for at least 6 months;

          2. Liver injury (at least one of the followings):

               1. AST&gt;1.0 ULN and AST&gt;ALT;

               2. TBIL&gt;2.0mg/dl;

               3. Ascites;

               4. Hepatic encephalopathy;

               5. Esophageal variceal bleeding;

               6. Hypersplenism

        Exclusion Criteria:

          1. Younger than 18 or older than 80;

          2. Other etiologies rather than alcoholic liver disease, including but not limited to the
             followings:

               1. Acute or chronic virologic hepatitis: Hepatitis A-E, Hepatitis caused by CMV,EBV,
                  etc.

               2. Autoimmune hepatitis, including PSC, PBC, AIH, IgG4 related liver disease

               3. Inherited metabolic liver diseases: Wilson disease;

               4. Others: Schistosomiasis

          3. HIV antibody positive;

          4. Malignancies including but not limited to HCC;

          5. Pregnancy;

          6. Hospital stay less than 24h;

          7. Refuse to sigh the informed consent;

          8. Combined with other improper situations determined by investigators.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jinjun Chen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jinjun Chen</last_name>
    <phone>0086-18588531001</phone>
    <email>chjj@smu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tingting Qi</last_name>
    <phone>+8615521287260</phone>
    <email>tingtingqi@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nanfang Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinjun Chen</last_name>
      <phone>+8615521287260</phone>
      <email>chjj@smu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Tingting Qi</last_name>
      <phone>+8615521287260</phone>
      <email>tingtingqi@126.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>People's hospital of Yangshan</name>
      <address>
        <city>Qingyuan</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dongguan dalang hospital</name>
      <address>
        <city>Dongguan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>People's hospital of Foshan Nanhai District</name>
      <address>
        <city>Foshan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Chen</last_name>
    </contact>
    <contact_backup>
      <email>cchenyan_2005@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Foshan</name>
      <address>
        <city>Foshan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lixian Wu</last_name>
      <email>546245868@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guangdong General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Guangzhou Eighth People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital,Guangzhou University of Chinese Medicine</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital,Jinan University</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Huizhou Central Hospital</name>
      <address>
        <city>Huizhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhanzhou Lin</last_name>
      <email>lzz0752@21.cn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Huizhou Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Huizhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xianhua Huang</last_name>
      <email>hxhabm@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Huizhou</name>
      <address>
        <city>Huizhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaohui Zhang</last_name>
      <email>zhanjiang1007@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Sixth People's Hospital of Huizhou</name>
      <address>
        <city>Huizhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gang Li</last_name>
      <email>ligang636@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Third People's hospital of Huizhou</name>
      <address>
        <city>Huizhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuhui Li</last_name>
      <email>lixuhui@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Enping</name>
      <address>
        <city>Jiangmen</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chongguang Zheng</last_name>
      <email>13929099567@139.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiping Central Hospital</name>
      <address>
        <city>Kaiping</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Second People's Hospital of Yuebei</name>
      <address>
        <city>Shaoguan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Peking University Shenzhen Hospital</name>
      <address>
        <city>Shenzhen</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Wu</last_name>
      <email>W567jing@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shenzhen Third People's Hospital</name>
      <address>
        <city>Shenzhen</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shunde Hospital of Southern Medical University</name>
      <address>
        <city>Shunde</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peng Wang</last_name>
      <email>1962wangpeng@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yangjiang Public Health Hospital</name>
      <address>
        <city>Yangjiang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Yingde City</name>
      <address>
        <city>Yingde</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>liangmin An</last_name>
      <email>542868087@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nongken Central Hospital</name>
      <address>
        <city>Zhanjiang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tengqing Li</last_name>
      <email>gdsnkyyxhnkltq@tom.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Zhaoqing</name>
      <address>
        <city>Zhaoqing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zhaoqing No.2 People's Hospital</name>
      <address>
        <city>Zhaoqing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zhongshan Second People's Hospital</name>
      <address>
        <city>Zhongshan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenjun Gao</last_name>
      <email>gaowenjun888@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2017</study_first_submitted>
  <study_first_submitted_qc>September 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2017</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Liver Diseases, Alcoholic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

